Construction method of zebra fish bacterial inflammation model
By injecting lipopolysaccharides into zebrafish, the impact of Chinese herbal extracts on inflammatory response is studied, and the problem of difficulty in constructing a bacterial inflammation model in the existing technology is solved, and effective verification of inflammation-related indicators is achieved.
Patent Information
- Application Number
- CN202411270017.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-11
- Publication Date
- 2024-11-08
AI Technical Summary
Existing biotechnology is difficult to effectively build bacterial inflammation models, especially when studying the effects of Chinese herbal medicines on inflammatory responses, there is a lack of reliable experimental animals and methods.
Using zebrafish as the experimental subject, anesthetize it in a diluted tricaine methanesulfonate solution and inject lipopolysaccharide (LPS) into the yolk sac, observe neutrophils and inflammatory factor IL-1β. , expression of IL-6 to verify the effect of Chinese herbal extracts on inflammation model.
The bacterial inflammation model of zebrafish was successfully constructed, the impact of Chinese herbal extracts on inflammation-related indicators was verified, and a feasible research method was provided to study the inhibitory effect of Chinese herbal medicine on inflammatory response.
Smart Images

Figure CN118901628A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, and in particular to a method for constructing a zebrafish bacterial inflammation model. Background Art
[0002] Inflammation is a response of the immune system to tissue damage and infection. Its main characteristic is that white blood cells (granulocytes, macrophages) gather around infected tissues. The immune system of zebrafish is very similar to that of mammals. When trauma occurs, neutrophils and macrophages respond to traumatic inflammation almost simultaneously. Neutrophils migrate quickly and are recruited to the site of injury first, followed by macrophages. After a few hours, the inflammation begins to subside, and macrophages and neutrophils leave the site of injury. Therefore, using zebrafish to construct a bacterial inflammation model is a feasible technical solution. Summary of the invention
[0003] The purpose of the present invention is to provide a method for constructing a zebrafish bacterial inflammation model.
[0004] To achieve the above purpose and other related purposes, the technical solution provided by the present invention is: a method for constructing a zebrafish bacterial inflammation model, wherein the zebrafish is placed in a 0.02% tricaine methanesulfonate solution diluted with E3 culture medium, which can be anesthetized in 1-2 minutes; after the zebrafish is anesthetized, the zebrafish is taken out, the zebrafish yolk sac is found under a stereo microscope, and then lipopolysaccharide is injected into the zebrafish yolk sac with an injection needle to establish an inflammation model.
[0005] Due to the application of the above technical solution, the present invention has the following advantages compared with the prior art:
[0006] The present invention takes zebrafish as the research object, starting from the breeding of adult and juvenile zebrafish, and by observing the neutrophils of juvenile fish; the expression of IL-1β and IL-6 inflammatory factors, will verify the effects of two kinds of Chinese herbal medicine extracts on the offspring zebrafish of LPS-induced inflammation model after treatment, and the effects on the inflammation-related indicators of zebrafish. BRIEF DESCRIPTION OF THE DRAWINGS
[0007] Figure 1 The phenotype of sample MTC zebrafish (n=30) (magnification: 40×, scale bar: 1 mm).
[0008] Figure 2 Fluorescence phenotype of zebrafish neutrophils (n=30, magnification: 40×, scale bar: 600 μm).
[0009] Figure 3 Average fluorescence intensity of zebrafish yolk sac (***P<0.001, **P<0.01, *P<0.05) (n=30).
[0010] Figure 4 Relative expression level of IL-1β mRNA in zebrafish (***P<0.001, n=30).
[0011] Figure 5 Relative expression level of IL-6 mRNA in zebrafish (**P<0.01, *P<0.05, n=30).
[0012] Figure 6 Phenotype of neutrophils in the zebrafish yolk sac.
[0013] Figure 7 Relative expression of zebrafish IL-6 gene. Compared with the model control group, **p<0.01.
[0014] Figure 8 Relative expression of zebrafish IL-10 gene. Compared with the model control group, ***p<0.001. DETAILED DESCRIPTION
[0015] The following is a description of the implementation of the present invention by means of specific embodiments. Those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in the embodiments.
[0016] See also Figure 1-8 . It should be noted that the structures, proportions, sizes, etc. illustrated in the drawings of this specification are only used to match the contents disclosed in the specification for people familiar with this technology to understand and read, and are not used to limit the limiting conditions under which the present invention can be implemented. Therefore, they have no substantive technical significance, and any structural modification, change in proportional relationship or adjustment of size. The following examples are provided to better understand the present invention, but are not intended to limit the present invention. The experimental methods in the following examples are all conventional methods unless otherwise specified. The experimental materials used in the following examples are all purchased from conventional biochemical reagent stores unless otherwise specified.
[0017] Some of the experimental instruments and reagents used in the embodiments of the present invention are as follows:
[0018] Fluorescence microscope (SZX7, Olympus, Japan); micromanipulator (M-3103, Yuyan, Shanghai, China); fluorescence quantitative PCR instrument (7500 / 7500Fast, Applied Biosystems, USA); LPS endotoxin (CAS: 93572-42-0, Aladdin, Shanghai, China), 3-aminobenzoic acid ethyl ester methanesulfonate (CAS: 886-86-2, Tianjin Xiensi Biochemical Technology Co., Ltd., China) dexamethasone (CAS: 50-02-2, Merck, Germany); reverse transcription kit (BL699A, Biosharp, Anhui, China); fluorescence quantitative PCR kit (BL698A, Biosharp, Anhui, China), and other reagents were of analytical grade.
[0019] Example 1: A method for constructing a zebrafish bacterial inflammation model
[0020] LPS (Lipopolysaccharides) is a component of the cell wall of Gram-negative bacteria. When these bacteria die or rupture, a large amount of LPS is released. LPS has an immunogenic stimulatory effect, which can stimulate the immune system to produce an inflammatory response, leading to a series of physiological changes.
[0021] In zebrafish, LPS can enter the body through the skin, digestive tract and other pathways, triggering an inflammatory response. Specifically, LPS first binds to Toll-like receptor 4 (TLR4) in zebrafish, activating downstream signaling pathways such as NF-κB and MAPK, and then inducing the production of inflammatory factors such as IL-1β and TNF-α. These inflammatory factors can cause vasodilation, increased blood flow, and leukocyte infiltration, leading to symptoms such as redness, swelling, heat and pain in local tissues. In short, LPS induces inflammation in zebrafish mainly by binding to TLR4, activating downstream signaling pathways, inducing the production of inflammatory factors, and triggering an inflammatory response.
[0022] The fish strains used in the experiment were wild-type AB zebrafish (WT / AB) and transgenic MPX zebrafish-Tg (mpx: EGFP). The breeding standards of zebrafish refer to the instructions of Westerfield. Zebrafish are raised in the company's zebrafish laboratory. The experimental animal ethics license number is USTS2024017. Transgenic MPX zebrafish and wild AB zebrafish were divided into two fish tanks and raised in a circulating water tank system with a temperature of 28±1℃, a conductivity of 500-550μS / cm, a salinity of 0.03%-0.04%, and a pH of 7.2-7.6. The lighting system was alternating 14h / 10h (light / darkness), and paramecium was fed every morning and evening.
[0023] In order to obtain zebrafish embryos, the adult zebrafish were placed in the aquarium at a ratio of 1:1 / 2:1 for male to female the day before the experiment. The lights were turned on the next morning, the baffles were removed, and the male and female zebrafish were allowed to mate and lay eggs naturally. In order to ensure the quality of the embryos, the embryo collection process should be controlled within 30 minutes as much as possible. The obtained embryos were stored in E3 culture medium. The culture dish contained 25 mL of 0.3% methylene blue 1×E3 solution, ensuring that every 100 mm 2 Place 50 embryos.
[0024] Testing system and sample size:
[0025] Experimental system: Transgenic MPX zebrafish; wild AB zebrafish
[0026] Zebrafish age: 3-5 days after fertilization
[0027] Sample size per group: 30 strips per well, 1 well per group
[0028] Adult fish feeding and breeding methods: in accordance with our company's standard feeding and breeding methods
[0029] Drug / Sample Preparation:
[0030] Scutellaria baicalensis extract (75% ethanol extract), main components: baicalin, baicalein; anti-inflammatory mechanism: inhibiting the inflammatory response by inhibiting the expression of pro-inflammatory factors (such as NF-κB, TNF-α, IL-6). Use a small amount of 75% ethanol to promote dissolution, then dilute and dissolve with standard aquaculture water, and after ultrasonic cleaning with an ultrasonic cleaning instrument for 5-10 minutes, the solution is in a uniformly dispersed suspension state, and is configured into a 2mg / mL mother solution, with a final ethanol concentration of no more than 1%, and is prepared before use.
[0031] Sample B: Bupleurum chinense extract (75% ethanol extract); Main ingredients: saikosaponins; Anti-inflammatory mechanism: Reduce the occurrence of inflammatory response by inhibiting cytokines such as TNF-α and IL-6. Use a small amount of 75% ethanol to promote dissolution, then dilute and dissolve with standard aquaculture water, and after ultrasonic treatment with an ultrasonic cleaning instrument for 5-10 minutes, the solution is in a uniformly dispersed suspension state, and is prepared into a 2 mg / mL mother solution, with a final ethanol concentration of no more than 1%, and is prepared before use.
[0032] Positive control (dexamethasone): white powder, diluted and dissolved with standard aquaculture water to prepare a 2 mg / mL stock solution, prepared before use.
[0033] Construction of LPS-induced inflammation model in zebrafish
[0034] The fluorescent zebrafish that were screened and cultured to 3dpf were used in the experiment. The experiment was divided into a control group (2nL PBS injected into the yolk sac) and a drug group (2nL 2mg / mL LPS injected into the yolk sac). The steps for establishing the model are as follows: First, the zebrafish was placed in a 0.02% tricaine methanesulfonate solution diluted with E3 culture medium, which can be anesthetized in 1-2 minutes; after the zebrafish was anesthetized, the zebrafish was taken out and placed under a stereo microscope to find the zebrafish yolk sac part, and then an injection needle (the capillary was made with a vertical needle puller) was used to inject 2nL of LPS per fish to establish an inflammatory model, and the blank control group was injected with 2nL PBS.
[0035] When the model is not established, there are almost no or only a few fluorescent cells recruited in the yolk sac of transgenic zebrafish. Therefore, the criterion for judging whether the model is successfully established is whether a large number of fluorescent cells are recruited in the LPS injection site (yolk sac).
[0036] Experimental Grouping
[0037] The tested zebrafish were divided into 9 groups, namely normal control group, model control group, positive control group, sample A treatment group (high, medium and low concentrations), and sample B treatment group (high, medium and low concentrations). The normal control group was injected with 2nL PBS solution through the zebrafish yolk sac, and the model control group, positive control group and sample treatment group were all microinjected with 2nLLPS solution (2mg / mL) through the zebrafish yolk sac to establish an inflammation model. The positive control group took dexamethasone (2mg / mL) after the injection of LPS solution (dexamethasone was taken into the zebrafish by dissolving it in the breeding water), and the sample treatment group took samples of different concentrations after the injection of LPS solution (the samples were taken into the zebrafish by dissolving it in the breeding water). After a period of time, the data analysis results were collected.
[0038] Drugs and samples for exploring MTC in zebrafish:
[0039] Zebrafish strain: Wild AB strain (WT / AB)
[0040] Experimental groups: 3 samples in total (2 experimental samples + 1 positive drug), 5 test concentrations for each sample, 30 zebrafish in each group.
[0041] Experimental method: After zebrafish were treated with samples of different concentrations for 48 hours, the number of deaths and sex of zebrafish in each experimental group were counted to determine the MTC of the sample; if the MTC could not be obtained in the initial concentration detection experiment, the detection concentration range of the sample would be expanded, with an upper limit of 2000 μg / mL or maximum solubility and a lower limit of 0.01 μg / mL.
[0042] Evaluation index: Count the number of zebrafish deaths and toxicity in the experimental group and determine the MTC of the sample.
[0043] Results display: 3 representative zebrafish images for each sample and concentration, and mortality statistics table.
[0044] 2.8 Determination of the number of neutrophils in zebrafish by samples
[0045] Zebrafish strain: Transgenic MPX strain zebrafish Tg(mpx:EGFP)
[0046] Experimental groups: 9 groups in total, 2 samples in total, 3 test concentrations for each sample (1 / 4MTC, 1 / 2MTC and MTC), and a normal control group, a model control group and a positive control group (selected by the client). 30 zebrafish in each group.
[0047] Experimental method: Inflammation was induced in zebrafish by injecting LPS solution (2 nL, 2 mg / mL) through the yolk sac. Two hours after the injection, the zebrafish larvae were observed to wake up normally, and the culture water was replaced with sample solutions of different concentrations. After 24 hours of treatment, the larvae were fixed with methylcellulose and photographed under a fluorescence microscope. The number of zebrafish neutrophils was measured and analyzed using image j image processing software.
[0048] Evaluation index: neutrophil count.
[0049] Results display: original pictures of 30 zebrafish in each group, original light quantitative graphs, and 10 zebrafish were selected to draw quantitative bar graphs and tables.
[0050] Determination of the expression of inflammatory factors IL-1β and IL-6 mRNA in zebrafish by qRT-PCR
[0051] Zebrafish strain: Wild AB strain (WT / AB)
[0052] Experimental groups: 9 groups in total. 2 samples in total, 3 test concentrations for each sample (usually 1 / 4MTC, 1 / 2MTC and MTC), and a normal control group, a model control group and a positive control group (selected by the client). 30 zebrafish in each group.
[0053] Experimental method: Inflammation was induced in zebrafish by injecting LPS solution (2nL, 2mg / mL) through the yolk sac. Two hours after the injection, the zebrafish fry were observed to wake up normally. The culture water was replaced with sample solutions of different concentrations. After 24 hours of treatment, each group of zebrafish was homogenized and lysed, RNA was extracted by TRIzol method, and RNA was reverse transcribed into cDNA by reverse transcription kit. Then, the mRNA expression of inflammatory factors IL-1β and IL-6 was detected by fluorescence quantitative PCR kit. The details are as follows:
[0054] (1) Extraction of total RNA
[0055] Transfer the zebrafish larvae to a 1.5 mL enzyme-free centrifuge tube and wash three times with sterile PBS. Add 1 mL of TRIzol
[0056] Reagent, shake gently and let stand for 5 minutes. Add 200μL chloroform, 750μL isopropanol and 1mL 75% anhydrous ethanol to the homogenate in turn to remove protein, precipitate RNA and rinse isopropanol. At room temperature, the precipitate at the bottom of the enzyme-free tube is dried until there is no water stain, add 10μL RNase-free water to dissolve the precipitate, detect the concentration of the dissolved RNA solution, and dilute the RNA solution to 300ng / μL.
[0057] (2) Reverse transcription
[0058] Reaction conditions: Mix gently, incubate at 50℃ for 5min, heat at 85℃ for 5s, and store the synthesized cDNA in aliquots at -20℃.
[0059] Table 1 Reverse transcription reaction system
[0060]
[0061] Real-time quantitative PCR
[0062] According to the following formula, the reaction system was prepared and centrifuged.
[0063] Table 2 qRT-PCR reaction system
[0064]
[0065] According to the above amplification conditions, real-time fluorescence quantitative PCR instrument was used for detection.
[0066] Table 3 Reaction procedure
[0067]
[0068] Evaluation indicators: expression of IL-Iβ and J16 inflammatory factors.
[0069] The results show: the original absorbance readings of the PCR instrument for the two inflammatory factor contents of all zebrafish, the original values of the inflammatory factor contents after data processing, and the quantitative bar graph.
[0070] Table 4 Primer list
[0071]
[0072] Data processing method: SPSS26 software was used for analysis, GraphPad Prism 8 was used for drawing, and data statistics were expressed as mean ± standard deviation. The experimental results were tested for normal distribution using SPSS software. If the data conformed to the normal distribution, the T parameter test or analysis of variance (ANOVA) was used for significance. If it did not conform to the normal distribution, a non-parametric test was used (the result P value <0.05 indicated a statistically significant difference).
[0073] 3. Experimental Results
[0074] 1. Determination of the maximum detectable concentration (MTC) of the sample
[0075] At 2000 μg / mL, there was no significant difference between the dexamethasone and sample A treatment groups and the blank control group. The zebrafish mortality rate was 100% compared with the blank control group. At 1000 μg / mL, there was no significant difference between the sample B treatment group and the blank control group. Therefore, 2000 μg / mL was selected as the MTC of dexamethasone and sample A treatment groups, 1000 μg / mL was selected as the MTC of dexamethasone and sample A treatment groups.
[0076] The concentration of μg / mL was used as MTC in sample B treatment group.
[0077] Zebrafish MTC phenotype:
[0078] Table 5 MTC exploration of samples in zebrafish (n=30)
[0079]
[0080]
[0081] Samples for determination of neutrophil numbers in zebrafish:
[0082] Compared with the blank control group, the number of neutrophils in the yolk sac of zebrafish in the model group was significantly increased, and the fluorescence intensity of neutrophils was significantly increased; compared with the model control group, the number of neutrophils in the yolk sac of zebrafish in the positive control and sample treatment groups decreased to varying degrees.
[0083] The fluorescence phenotype of zebrafish neutrophils, such as Figure 2 shown.
[0084] Statistical analysis of mean fluorescence intensity of zebrafish yolk sac, e.g. Figure 3 shown.
[0085] Determination of the expression of inflammatory factors IL-1β and IL-6 mRNA in zebrafish by qRT-PCR.
[0086] like Figure 4As shown, compared with the blank group, the expression of IL-1β and IL-6 mRNA in the model group was significantly increased, indicating that the modeling was successful. Compared with the model group, the expression of IL-1β and IL-6 mRNA in the sample and dexamethasone-treated groups increased or decreased to varying degrees.
[0087] Example 2: A method for constructing a zebrafish bacterial inflammation model
[0088] This example uses zebrafish as the research object, starting from the reproduction of adult zebrafish and fry, and by observing the neutrophils of fry; the expression of IL-1β and IL-6 inflammatory factors, will verify the effects of two Chinese herbal medicine extracts on the offspring zebrafish of the LPS-induced inflammation model after treatment, and the effects on the inflammation-related indicators of zebrafish.
[0089] The zebrafish were divided into three groups: normal control group, model control group and anti-inflammatory group. The normal control group was not injected with LPS, while the model control group and anti-inflammatory group were injected with LPS (LPS was injected into the zebrafish by injection into the yolk sac). The anti-inflammatory group took anti-inflammatory drugs such as indomethacin, aspirin, ibuprofen and diclofenac before LPS injection.
[0090] After taking anti-inflammatory drugs for a period of time, the number of neutrophils in the zebrafish yolk sac was observed, and the expression of inflammatory-related factors such as TNF-α, COX-2, IL-1β, IL-6 and IL-10 was detected by Q-PCR.
[0091] like Figure 1 As shown, the yellow dotted area is the yolk sac, and the green particles are neutrophils. It can be seen that the neutrophils in the yolk sac of the group taking / injecting anti-inflammatory drugs are more obvious than those in the model control group, and there is no large-scale recruitment of neutrophils.
[0092] Taking IL-6 and IL-10 genes as an example, a bar chart is provided as follows Figure 2 shown. Figure 2 It can be seen that the expression of IL-6 gene was significantly downregulated in zebrafish in the group taking / injecting anti-inflammatory drugs compared with the model control group.
[0093] Figure 3 It can be seen that the expression of IL-10 gene was significantly downregulated in zebrafish in the group taking / injecting anti-inflammatory drugs compared with the model control group.
[0094] 1. After a comparative experiment with 30 zebrafish in each group, the number of neutrophils in the yolk sac of the group taking / injecting anti-inflammatory drugs was slightly more than that of the normal control group, and the neutrophil recruitment of the model control group did not occur, and the inflammatory factors TNF-α, COX-2, IL-1β, IL-6 and IL-10 were significantly downregulated.
[0095] 2. This experiment confirmed that indomethacin, aspirin, ibuprofen and diclofenac have significant anti-inflammatory effects and inhibit the expression of inflammatory-related factors such as TNF-α, COX-2, IL-1β, IL-6 and IL-10.
[0096] The above description is only used to explain the preferred embodiments of the present invention, and is not intended to limit the present invention in any form. Therefore, any modifications or changes made to the present invention under the same inventive spirit should still be included in the scope of protection intended by the present invention.
Claims
1. A method for constructing a zebrafish bacterial inflammation model, characterized in that: The zebrafish was placed in a 0.02% tricaine methanesulfonate solution diluted in E3 culture medium, which could be anesthetized for 1-2 minutes. After the zebrafish was anesthetized, the zebrafish was taken out and placed under a stereo microscope to find the zebrafish yolk sac part, and then lipopolysaccharide was injected into the zebrafish yolk sac part with an injection needle to establish an inflammation model.
Citation Information
Patent Citations
Method for constructing chicken model for transgenosis and production exogenous protein
CN101352157A
Zebrafish model for inflammatory disease and screening method of Anti-inflammatory agent using the same
KR1020110054952A
Yolk sac stem cells and their uses
US5744347A
Infection-related disease model, preparation method thereof, and screening method for immunoactive substances
WO2022169302A1
Cited By
Construction method and application of zebra fish sepsis model
CN119404809A
Construction method and application of a zebrafish sepsis model
CN119404809B
Method for constructing vasculitis model in zebra fish
CN121058583A
